Proposed mechanisms remain hypothetical and include altered optic nerve perfusion, nocturnal hypotension related to weight loss, or individual susceptibility
Faster results occur in patients with higher baseline weights and stricter adherence to reduced calorie intake
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ozempic specifically for glycaemic control in type 2 diabetes, not for weight loss
When a peptide is synthesized, there's a risk of creating fragments, failed sequences, or including residual solvents from the manufacturing process
Regardless of other concerning symptoms, if injection site bruises are causing you pain or discomfort, contact your healthcare provider
Am I a Good Candidate for Semaglutide Therapy